The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess whether intermittent real-time continuous glucose monitoring (CGM) improves glycemic control and pregnancy outcome in unselected women with pregestational diabetes. RESEARCH DESIGN AND METHODS: A total of 123 women with type 1 diabetes and 31 women with type 2 diabetes were randomized to use real-time CGM for 6 days at 8, 12, 21, 27, and 33 weeks in addition to routine care, including self-monitored plasma glucose seven times daily, or routine care only. To optimize glycemic control, real-time CGM readings were evaluated by a diabetes caregiver. HbA1c, self-monitored plasma glucose, severe hypoglycemia, and pregnancy outcomes were recorded, with large-for-gestational-age infants as the primary outcome. RESULTS: Women assigned to real-time CGM (n = 79) had baseline HbA1c similar to that of women in the control arm (n = 75) (median 6.6 [range 5.3–10.0] vs. 6.8% [5.3–10.7]; P = 0.67) (49 [34–86] vs. 51 mmol/mol [34–93]). Forty-nine (64%) women used real-time CGM per protocol. At 33 weeks, HbA1c (6.1 [5.1–7.8] vs. 6.1% [4.8–8.2]; P = 0.39) (43 [32–62] vs. 43 mmol/mol [29–66]) and self-monitored plasma glucose (6.2 [4.7–7.9] vs. 6.2 mmol/L [4.9–7.9]; P = 0.64) were comparable regardless of real-time CGM use, and a similar fraction of women had experienced severe hypoglycemia (16 vs. 16%; P = 0.91). The prevalence of large-for-gestational-age infants (45 vs. 34%; P = 0.19) and other perinatal outcomes were comparable between the arms. CONCLUSIONS: In this randomized trial, intermittent use of real-time CGM in pregnancy, in addition to self-monitored plasma glucose seven times daily, did not improve glycemic control or pregnancy outcome in women with pregestational diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“There was also lower incidence of large for gestational age (odds ratio [OR], 0.51; 95% CI, 0$28–0.90; P = .0210)”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“The CONCEPTT study’s participants were randomly assigned to either CGM in addition to capillary glucose monitoring or capillary glucose monitoring alone and showed a modest reduction in A1C levels, increased time in target, reduced hyperglycemia, and less glycemic variability.123”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“and 1-day shorter length of hospital stay (P = .0091) in women with T1D on multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII).”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“fewer incidences of neonatal hypoglycemia (0.45; 95% CI, 0.22–0.89; P = .0250)”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“fewer neonatal intensive care admissions lasting more than 24 hours (0.48; 95% CI, 0.26–0.86; P = .0157)”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [123]
Experimental — accuracy not yet measured
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intrauterine growth curves based on ultrasonically estimated foetal weights
Maršál, K., Persson, P., Larsen, T., Lilja, H., Selbing, A., & Sultan, B. (1996) · Acta Paediatrica · doi:10.1111/j.1651-2227.1996.tb14164.x · Cited by 1,865 · cited 1×
“, infant birth weight $90th centile adjusted for sex and gestational age (31)] was predefined as the primary outcome of this study.”
MethodContinuous glucose monitoring and intensive treatment of type 1 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805017 · Cited by 1,559
Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes
Bergenstal, R. M., Tamborlane, W. V., Ahmann, A., Buse, J. B., Dailey, G., Davis, S. N., Joyce, C., Peoples, T., Perkins, B. A., Welsh, J. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002853 · Cited by 894
Clausen, T. D., Mathiesen, E. R., Hansen, T., Pedersen, O., Jensen, D. M., Lauenborg, J., & Damm, P. (2008) · Diabetes Care · doi:10.2337/dc07-1596 · Cited by 724
Self-citationPickup, J. C., Freeman, S. C., & Sutton, A. J. (2011) · BMJ · doi:10.1136/bmj.d3805 · Cited by 541 · cited 2×
“Recent data indicate the importance of frequent real-time CGM use (16).”
BackgroundDeiss, D., Bolinder, J., Riveline, J.-P., Battelino, T., Bosi, E., Tubiana-Rufi, N., Kerr, D., & Phillip, M. (2006) · Diabetes Care · doi:10.2337/dc06-1134 · Cited by 539
The effect of continuous glucose monitoring in well-controlled type 1 diabetes
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0108 · Cited by 399
Murphy, H. R., Rayman, G., Lewis, K., Kelly, S., Johal, B., Duffield, K., Fowler, D., Campbell, P. J., & Temple, R. C. (2008) · BMJ · doi:10.1136/bmj.a1680 · Cited by 358 · cited 6×
“However, the relatively low number of per-protocol users has also been observed in the nonpregnant population (17,18), and the average use of CGM was comparable to the former study on pregnant women (27).”
BackgroundResultInfluentialHbA1c levels are significantly lower in early and late pregnancy
Nielsen, L. R., Ekbom, P., Damm, P., Glümer, C., Frandsen, M. M., Jensen, D. M., & Mathiesen, E. R. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1200 · Cited by 331
Self-citationEffectiveness of Continuous Glucose Monitoring in a Clinical Care Environment
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2010) · Diabetes Care · doi:10.2337/dc09-1502 · Cited by 313
Cited by
Battelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Feig, D. S., Donovan, L. E., Corcoy, R., Murphy, K. E., Amiel, S. A., Hunt, K. F., Asztalos, E., Barrett, J. F. R., Sanchez, J. J., de Leiva, A., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32400-5 · Cited by 803
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
The importance of nutrition in pregnancy and lactation: lifelong consequences
Marshall, N. E., Abrams, B., Barbour, L. A., Catalano, P., Christian, P., Friedman, J. E., Hay, W. W., Hernandez, T. L., Krebs, N. F., Oken, E., et al. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.12.035 · Cited by 709
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes
Rodbard, D. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0035 · Cited by 458
“46,47 Additional randomized trials have been initiated.”
7. Diabetes Technology: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s007 · Cited by 358
“Two studies employing intermittent use of rtCGM showed no difference in neonatal outcomes in women with type 1 diabetes (85) or gestational diabetes mellitus (86).”
Background7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
7. Diabetes Technology: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s007 · Cited by 250
Kristensen, K., Ögge, L. E., Sengpiel, V., Kjölhede, K., Dotevall, A., Elfvin, A., Knop, F. K., Wiberg, N., Katsarou, A., Shaat, N., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4850-0 · Cited by 210
7. Diabetes Technology: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s007 · Cited by 202
7. Diabetes Technology: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s007 · Cited by 179
“Two studies employing intermittent use of real-time CGM showed no difference in neonatal outcomes in women with type 1 diabetes (97) or gestational diabetes mellitus (98).”
BackgroundManagement of Preexisting Diabetes in Pregnancy: A Review
Alexopoulos, A.-S., Blair, R., & Peters, A. L. (2019) · JAMA · doi:10.1001/jama.2019.4981 · Cited by 174
Scott, E. M., Bilous, R. W., & Kautzky-Willer, A. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0386 · Cited by 153
Diabetes in pregnancy: a new decade of challenges ahead
the Diabetic Pregnancy Study Group, Schaefer-Graf, U., Napoli, A., & Nolan, C. J. (2018) · Diabetologia · doi:10.1007/s00125-018-4545-y · Cited by 118
Voormolen, D. N., DeVries, J. H., Sanson, R. M. E., Heringa, M. P., de Valk, H. W., Kok, M., van Loon, A. J., Hoogenberg, K., Bekedam, D. J., Brouwer, T. C. B., et al. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13310 · Cited by 151
Law, G. R., Ellison, G. T. H., Secher, A. L., Damm, P., Mathiesen, E. R., Temple, R., Murphy, H. R., & Scott, E. M. (2015) · Diabetes Care · doi:10.2337/dc15-0070 · Cited by 127
Self-citationBailey, T. S., Grunberger, G., Bode, B. W., Handelsman, Y., Hirsch, I. B., Jovanovič, L., Roberts, V. L., Rodbard, D., Tamborlane, W. V., & Walsh, J. S. A. (2016) · Endocrine Practice · doi:10.4158/ep151124.cs · Cited by 149
Continuous glucose monitoring targets in type 1 diabetes pregnancy: every 5% time in range matters
Murphy, H. R. (2019) · Diabetologia · doi:10.1007/s00125-019-4904-3 · Cited by 137
Improving pregnancy outcomes in women with diabetes mellitus: modern management
Ringholm, L., Damm, P., & Mathiesen, E. R. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0197-3 · Cited by 141
Self-citationDiabetes in pregnancy outcomes: A systematic review and proposed codification of definitions
The International Association of Diabetes in Pregnancy Study Group (IADPSG) Working Group on Outcome Definitions, Feig, D. S., Corcoy, R., Jensen, D. M., Kautzky‐Willer, A., Nolan, C. J., Oats, J. J. N., Sacks, D. A., Caimari, F., & McIntyre, H. D. (2015) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2640 · Cited by 100
WEI, Q., SUN, Z., YANG, Y., YU, H., DING, H., & WANG, S. (2016) · Scientific Reports · doi:10.1038/srep19920 · Cited by 99
McCance, D. R. (2015) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2015.04.009 · Cited by 95
Moon, J. S., Kang, S., Choi, J. H., Lee, K. A., Moon, J. H., Chon, S., Kim, D. J., Kim, H. J., Seo, J. A., Kim, M. K., et al. (2024) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2024.0249 · Cited by 90
Kang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 84
Secher, A. L., Parellada, C. B., Ringholm, L., Ásbjörnsdóttir, B., Damm, P., & Mathiesen, E. R. (2014) · Diabetes Care · doi:10.2337/dc14-0896 · Cited by 81
Self-citationAlfadhli, E., Osman, E., & Basri, T. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0161-5 · Cited by 69
Barbour, L. A. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000079 · Cited by 73
“In another study of intermittent use of real-time CGM (where results are simultaneously displayed), there was no improvement of glycemic control or macrosomia [67].”
BackgroundTranslating HbA1c measurements into estimated average glucose values in pregnant women with diabetes
Law, G. R., Gilthorpe, M. S., Secher, A. L., Temple, R., Bilous, R., Mathiesen, E. R., Murphy, H. R., & Scott, E. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4205-7 · Cited by 77
Self-citationTechniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes
Moy, F. M., Ray, A., Buckley, B. S., & West, H. M. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009613.pub3 · Cited by 72
Wood, A., O'Neal, D., Furler, J., & Ekinci, E. I. (2018) · Internal Medicine Journal · doi:10.1111/imj.13770 · Cited by 67
Benhalima, K., Beunen, K., Siegelaar, S. E., Painter, R., Murphy, H. R., Feig, D. S., Donovan, L. E., Polsky, S., Buschur, E., Levy, C. J., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00116-x · Cited by 61
Self-citationExperiences of closed‐loop insulin delivery among pregnant women with Type 1 diabetes
Farrington, C., Stewart, Z. A., Barnard, K., Hovorka, R., & Murphy, H. R. (2017) · Diabetic Medicine · doi:10.1111/dme.13406 · Cited by 65
Paramasivam, S. S., Chinna, K., Singh, A. K. K., Ratnasingam, J., Ibrahim, L., Lim, L. L., Tan, A. T. B., Chan, S. P., Tan, P. C., Omar, S. Z., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13649 · Cited by 69
Cordua, S., Secher, A. L., Ringholm, L., Damm, P., & Mathiesen, E. R. (2013) · Diabetic Medicine · doi:10.1111/dme.12246 · Cited by 66
Self-citationManagement of type 1 diabetes in pregnancy
Feldman, A. Z., & Brown, F. M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0765-z · Cited by 65
Wyckoff, J., Lapolla, A., Asias-Dinh, B. D., Barbour, L. A., Brown, F. M., Catalano, P. M., Corcoy, R., Renzo, G. C. D., Drobycki, N., Kautzky‐Willer, A., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf288 · Cited by 60
“Adequately powered RCTs comparing continual rtCGM with SMBG in pregnant individuals with T2DM that demonstrate improvements in any of the outcomes prioritized by the panel were not identified (200-202 , 213).”
Mathiesen, J. M., Secher, A. L., Ringholm, L., Nørgaard, K., Hommel, E., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2014) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.837444 · Cited by 58
Self-citationRisk factors for large-for-gestational age infants in pregnant women with type 1 diabetes
Morrens, A., Verhaeghe, J., Vanhole, C., Devlieger, R., Mathieu, C., & Benhalima, K. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-0958-0 · Cited by 58
Parellada, C. B., Ásbjörnsdóttir, B., Ringholm, L., Damm, P., & Mathiesen, E. R. (2014) · Diabetic Medicine · doi:10.1111/dme.12558 · Cited by 57
Self-citationon behalf of the CONCEPTT Collaborative Group, Feig, D. S., Asztalos, E., Corcoy, R., De Leiva, A., Donovan, L., Hod, M., Jovanovic, L., Keely, E., Kollman, C., et al. (2016) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-016-0961-5 · Cited by 49
Murphy, H. R., Feig, D. S., Sanchez, J. J., de Portu, S., Sale, A., & the CONCEPTT Collaborative Group (2019) · Diabetic Medicine · doi:10.1111/dme.14046 · Cited by 49
Benefits of Real-Time Continuous Glucose Monitoring in Pregnancy
Yamamoto, J. M., & Murphy, H. R. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0667 · Cited by 52
CGM, Pregnancy, and Remote Monitoring
Polsky, S., & Garcetti, R. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2017.0023 · Cited by 43
Bytoft, B., Knorr, S., Vlachova, Z., Jensen, R. B., Mathiesen, E. R., Beck‐Nielsen, H., Gravholt, C. H., Jensen, D. M., Clausen, T. D., Mortensen, E. L., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0168 · Cited by 47
Self-citationNørgaard, S. K., Vestgaard, M. J., Jørgensen, I. L., Ásbjörnsdóttir, B., Ringholm, L., McIntyre, D. H., Damm, P., & Mathiesen, E. R. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.014 · Cited by 47
Self-citationBellido, V., Aguilera, E., Cardona‐Hernandez, R., Díaz-Soto, G., de Villar, N. G. P., César, M. J. P., & Ampudia‐Blasco, F. J. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221088601 · Cited by 46
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes
Jones, L. V., Ray, A., Moy, F. M., & Buckley, B. S. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009613.pub4 · Cited by 46
Carreiro, M. P., Nogueira, A. I., & Ribeiro‐Oliveira, A. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020011 · Cited by 43
“However, it still does not normalize outcomes, even when, according to current guidelines [28,29], excellent glucose control is achieved.”
BackgroundDalfrà, M. G., Chilelli, N. C., Di Cianni, G., Mello, G., Lencioni, C., Biagioni, S., Scalese, M., Sartore, G., & Lapolla, A. (2013) · International Journal of Endocrinology · doi:10.1155/2013/279021 · Cited by 41
McCance, D. R., & Casey, C. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.008 · Cited by 40
Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGM
Ziegler, R., Heinemann, L., Freckmann, G., Schnell, O., Hinzmann, R., & Kulzer, B. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/1932296820905577 · Cited by 39
Masked hypoglycemia in pregnancy
Naik, D., Shyamasunder, A. H., Mruthyunjaya, M. D., Patil, R. G., Paul, T. V., Christina, F., Inbakumari, M., Jose, R., Lionel, J., Regi, A., et al. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12485 · Cited by 40
Ringholm, L., Roskjær, A. B., Engberg, S., Andersen, H. U., Secher, A. L., Damm, P., & Mathiesen, E. R. (2019) · Diabetologia · doi:10.1007/s00125-018-4794-9 · Cited by 40
Self-citationTime in range in pregnancy: is there a role?
Wyckoff, J. A., & Brown, F. M. (2021) · Diabetes Spectrum · doi:10.2337/ds20-0103 · Cited by 39
Mathiesen, E. R. (2016) · Diabetes Care · doi:10.2337/dc16-1647 · Cited by 38
Self-citationBenhalima, K., Durnwald, C. P., Sweeting, A., Adams, D., Addala, A., Battelino, T., Bergenstal, R. M., Carlson, A. L., Donovan, L., Franco, D. R., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00335-3 · Cited by 37
Self-citationPotentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes
Søholm, J. C., Vestgaard, M. J., Ásbjörnsdóttir, B., Do, N. C., Pedersen, B. W., Storgaard, L., Nielsen, B. B., Ringholm, L., Damm, P., & Mathiesen, E. R. (2021) · Diabetologia · doi:10.1007/s00125-021-05482-8 · Cited by 37
Self-citationDiabetes Technology Use Among Pregnant and Nonpregnant Women with T1D in the T1D Exchange
Polsky, S., Wu, M., Bode, B. W., DuBose, S. N., Goland, R., Maahs, D. M., Foster, N. C., Peters, A. L., Levy, C. J., Shah, V. N., et al. (2018) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0033 · Cited by 36
“Previous randomized controlled trials comparing intermittent use of CGM to either constant use 42 or standard of care alone 21,22,43 were inconclusive about whether CGM use affects maternal and fetal outcomes.”
Kapur, A., McIntyre, D. H., & Hod, M. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.009 · Cited by 35
Feig, D. S., & Murphy, H. R. (2018) · Diabetic Medicine · doi:10.1111/dme.13585 · Cited by 35
Kgosidialwa, O., Bogdanet, D., Egan, A. M., O’Shea, P. M., Newman, C., Griffin, T. P., McDonagh, C., O'Shea, C., Carmody, L. A., Cooray, S. D., et al. (2021) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16825 · Cited by 34
Wilkie, G., Melnik, V. Y., Brainard, L., Antonioli, S. S., Nelson, B. B., Leung, K., & Leftwich, H. K. (2023) · American Journal of Obstetrics & Gynecology MFM · doi:10.1016/j.ajogmf.2023.100969 · Cited by 34
Secher, A. L., Stage, E., Ringholm, L., Barfred, C., Damm, P., & Mathiesen, E. R. (2013) · Diabetic Medicine · doi:10.1111/dme.12383 · Cited by 34
Self-citationDiabetes: the role of continuous glucose monitoring
Kluemper, J. R., Smith, A. C., & Wobeter, B. R. (2022) · Drugs in Context · doi:10.7573/dic.2021-9-13 · Cited by 33
Panyakat, W. S., Phatihattakorn, C., Sriwijitkamol, A., Sunsaneevithayakul, P., Phaophan, A., & Phichitkanka, A. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817752374 · Cited by 33
Chang, V. Y. X., Tan, Y., Ang, W. H. D., & Lau, Y. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.109192 · Cited by 32
Knorr, S., Clausen, T. D., Vlachová, Z., Bytoft, B., Damm, P., Beck‐Nielsen, H., Jensen, D. M., Juul, S., & Gravholt, C. H. (2015) · Diabetes Care · doi:10.2337/dc15-0223 · Cited by 32
“(34) described a tighter glycemic regulation among pregnant women with type 1 diabetes during 2009 to 2011”
BackgroundSelf-citationRingholm, L., Secher, A. L., Pedersen‐Bjergaard, U., Thorsteinsson, B., Andersen, H. U., Damm, P., & Mathiesen, E. R. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.06.002 · Cited by 30
“In fact, the major reason for rejecting participation was the possibility of allocation to real-time CGM [12].”
BackgroundResultSelf-citationIntensive Glycemic Treatment During Type 1 Diabetes Pregnancy: A Story of (Mostly) Sweet Success!
Murphy, H. R. (2018) · Diabetes Care · doi:10.2337/dci18-0001 · Cited by 30
Wyckoff, J., Lapolla, A., Asias-Dinh, B. D., Barbour, L. A., Brown, F. M., Catalano, P. M., Corcoy, R., Renzo, G. C. D., Drobycki, N., Kautzky‐Willer, A., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf116 · Cited by 30
“Adequately powered RCTs comparing continual rtCGM with SMBG in pregnant individuals with T2DM that demonstrate improvements in any of the outcomes prioritized by the panel were not identified 200–202 , 213 .”
InfluentialTumminia, A., Milluzzo, A., Festa, C., Fresa, R., Pintaudi, B., Scavini, M., Vitacolonna, E., Napoli, A., & Sciacca, L. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.03.013 · Cited by 29
Sola‐Gazagnes, A., Faucher, P., Jacqueminet, S., Ciangura, C., Dubois‐Laforgue, D., Mosnier-Pudar, H., Roussel, R., & Larger, É. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.08.001 · Cited by 29
Voormolen, D. N., DeVries, J. H., Evers, I. M., Mol, B. W., & Franx, A. (2013) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000002 · Cited by 28
GLU: a software package for analysing continuously measured glucose levels in epidemiology
Millard, L. A. C., Patel, N., Tilling, K. M., Lewcock, M., Flach, P. A., & Lawlor, D. A. (2020) · International Journal of Epidemiology · doi:10.1093/ije/dyaa004 · Cited by 28
Milln, J., Walugembe, E., Ssentayi, S., Nkabura, H., Jones, A. G., & Nyirenda, M. (2020) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-020-03325-9 · Cited by 27
Feig, D. S. (2022) · Diabetes Care · doi:10.2337/dci21-0027 · Cited by 25
Burk, J., Ross, G. P., Hernandez, T. L., Colagiuri, S., & Sweeting, A. (2025) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2025.04.010 · Cited by 26
Sibiak, R., Gutaj, P., Mrzewka-Rogacz, B., Mantaj, U., & Wender-Ożegowska, E. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0194 · Cited by 25
Type 1 Diabetes in Pregnancy: A Review of Complications and Management
Huda, M. S. B., Jaffar, F., & Laycock, K. (2021) · Current Diabetes Reviews · doi:10.2174/1573399818666211105124829 · Cited by 25
Planejamento, metas e monitorização do diabetes durante a gestação
Zajdenverg, L., Façanha, C. F. S., Dualib, P. M., Golbert, A., Negrato, C. A., & Bertoluci, M. C. (2022) · Conectando Pessoas eBooks · doi:10.29327/557753.2022-12 · Cited by 26
Time in Range and Pregnancy Outcomes in People with Diabetes Using Continuous Glucose Monitoring
Bartal, M. F., Cornthwaite, J. A. A., Ghafir, D., Ward, C., Ortíz, G., Louis, A., Cornthwaite, J., Chauhan, S. S. P., & Sibai, B. M. (2022) · American Journal of Perinatology · doi:10.1055/a-1904-9279 · Cited by 24
Perea, V., César, M. J. P., Megía, A., Goya, M., Wägner, A. M., Guedes, B. V., Seguí, N., Montañez, M. D., & Vinagre, I. (2022) · Diabetologia · doi:10.1007/s00125-022-05717-2 · Cited by 24
Do, N. C., Secher, A. L., Cramon, P. K., Ringholm, L., Watt, T., Damm, P., & Mathiesen, E. R. (2016) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.13048 · Cited by 24
Self-citationSzmuilowicz, E. D., Barbour, L. A., Brown, F. M., Durnwald, C. P., Feig, D. S., O’Malley, G., Polsky, S., & Aleppo, G. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241239341 · Cited by 23
Continuous Glucose Monitoring for Management of Type 2 Diabetes and Perinatal Outcomes
Padgett, C. E., Ye, Y., Champion, M. L., Fleenor, R. E., Orfanakos, V. B., Casey, B. M., & Battarbee, A. N. (2024) · Obstetrics and Gynecology · doi:10.1097/aog.0000000000005609 · Cited by 23
Secher, A. L., Bytoft, B., Tabor, A., Damm, P., & Mathiesen, E. R. (2015) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.1111/aogs.12707 · Cited by 22
Self-citation1,5-Anhydroglucitol and Neonatal Complications in Pregnancy Complicated by Diabetes
Wright, L. A.-C., Hirsch, I. B., Gooley, T., & Brown, Z. A. (2015) · Endocrine Practice · doi:10.4158/ep14437.or · Cited by 22
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes
Moy, F. M., Ray, A., & Buckley, B. S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009613.pub2 · Cited by 22
Rizos, E. C., Markozannes, G., Charitakis, N., Filis, P., Stoimeni, A. E., Nørgaard, K., Ntzani, E. E., & Tsilidis, K. K. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0599 · Cited by 21
Stephansson, O., & Sandström, A. (2024) · Journal of Internal Medicine · doi:10.1111/joim.13823 · Cited by 21
Insulin therapy for the treatment of type 1 diabetes during pregnancy
Lenhard, M. J., & Kinsley, B. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.864631 · Cited by 21
Visser, G. H. A., & de Valk, H. W. (2014) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2014.08.005 · Cited by 22
Callesen, N., Secher, A. L., Cramon, P. K., Ringholm, L., Watt, T., Damm, P., & Mathiesen, E. R. (2015) · Diabetic Medicine · doi:10.1111/dme.12777 · Cited by 21
Self-citationA Covalently Imprinted Photonic Crystal for Glucose Sensing
Xue, F., Duan, T.-R., Huang, S., Wang, Q., Xue, M., & Meng, Z. (2013) · Journal of Nanomaterials · doi:10.1155/2013/530701 · Cited by 21
Affres, H., Sénat, M., Letourneau, A., Deruelle, P., Coustols-Valat, M., Bouchghoul, H., & Bouyer, J. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.11.002 · Cited by 21
Werzowa, J. M., Pacini, G., Hecking, M., Fidler, C., Haidinger, M., Brath, H., Thomas, A., Säemann, M. D., & Tura, A. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.07.014 · Cited by 20
“, Comparison of glycemic co s Complications (2015), http in subjects under special circumstances when glycemic patterns are less well understood such as during hemodialysis and in women with gestational diabetes (Chantrel et al., 2014; Secher et al., 2013).”
Background
Metadata
- Authors
- Secher, A. L., Ringholm, L., Andersen, H. U., Damm, P., & Mathiesen, E. R.
- Affiliations
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- Steno Diabetes Center, Gentofte, Denmark
- Corresponding author
- Secher, Anna L.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-06-12
- Volume
- 36
- Issue
- 7
- Pages
- 1877-1883
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3687305
- OpenAlex
- W2107291591
- Cited by
- 214
- References
- 36
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 15 · 2023: 9 · 2022: 17 · 2021: 18 · 2020: 12 · 2019: 18 · 2018: 26 · 2017: 15 · 2016: 20 · 2015: 14 · 2014: 11 · 2013: 12
- FWCI
- 21.26
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Keywords
- real-time continuous glucose monitoring, pregnancy, pregestational diabetes, type 1 diabetes, type 2 diabetes, glycemic control, HbA1c, severe hypoglycemia, large for gestational age, perinatal outcomes, gestational diabetes management
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Pregnancy, Pregnancy Outcome, Blood Glucose Self-Monitoring, Treatment Outcome, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
